1-5 of 5
Alex J Szubert, MSc
Close
Sort by
Journal Articles

Sequential Immunomodulatory Drug (IMiD) and Proteosome Inhibitor Therapy Improves Response Rates in Newly Diagnosed Multiple Myeloma: Preliminary Results From the Myeloma XI Trial

Charlotte Pawlyn, MD, Faith E. Davies, MD, Walter M Gregory, PhD, Alex J Szubert, MSc, Sue E Bell, DPhil, Jacqueline Ouzman, PhD, Mark T Drayson, MD, Roger G Owen, MD, Graham H Jackson, MD, Nigel H Russell, MD, Gareth J. Morgan, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 335.
https://doi.org/10.1182/blood.V120.21.335.335
Published: 2012
Journal Articles

MRC Myeloma IX, 6 Year Median Follow-up (FU) Highlights the Importance of Long-Term FU in Myeloma Clinical Trials and Differential Effects of Thalidomide in High- and Low-Risk Disease

Gareth J Morgan, MD PhD, Faith E Davies, MD, Walter M Gregory, PhD, Sue E Bell, DPhil, Alex J Szubert, MSc, Gordon Cook, Mark T Drayson, MD, Roger G Owen, MD, Fiona M Ross, DPhil, Graham H Jackson, MD, J. Anthony Child, MD
Journal: Blood
Blood (2011) 118 (21): 993.
https://doi.org/10.1182/blood.V118.21.993.993
Published: 2011
Journal Articles

The Interaction of Response and FISH-Based Risk Stratification to Better Define Clinical Outcome in Myeloma

Kevin D Boyd, MD, Fiona M Ross, DPhil, Mark T Drayson, MD, Roger G Owen, MD, Alex J Szubert, MSc, Walter M Gregory, PhD, Christopher P Wardell, PhD, Faith E Davies, MD, Graham H Jackson, MD, PhD, J. Anthony Child, MD, Gareth J Morgan, MD PhD
Journal: Blood
Blood (2011) 118 (21): 1823.
https://doi.org/10.1182/blood.V118.21.1823.1823
Published: 2011
Journal Articles

Thalidomide Maintenance Significantly Improves Progression-Free Survival (PFS) and Overall Survival (OS) of Myeloma Patients When Effective Relapse Treatments Are Used: MRC Myeloma IX Results

Gareth J Morgan, MD, PhD, Faith E. Davies, MD, Walter M. Gregory, PhD, Sue E. Bell, PhD, Alex J. Szubert, MSc, Nuria Navarro-Coy, MPhil, Mark T. Drayson, MD, PhD, Roger G. Owen, MD, Gordon Cook, MD, Fiona M. Ross, PhD, Graham H. Jackson, MD, J. Anthony Child, MD
Journal: Blood
Blood (2010) 116 (21): 623.
https://doi.org/10.1182/blood.V116.21.623.623
Published: 2010
Journal Articles

Genetic Variations Associated with Overall and Progression-Free Survival in Multiple Myeloma Patients Treated with Thalidomide Combinations.

David C Johnson, BSc, Walter M Gregory, PhD, Nicholas J Dickens, DPhil, Brian A Walker, PhD, Alex J Szubert, MSc, Faith E Davies, MD, Brian G M Durie, MD, Brian G Van Ness, PhD, Gareth J Morgan, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 426.
https://doi.org/10.1182/blood.V114.22.426.426
Published: 2009